Search Results - "Rechenmacher, Michael"
-
1
Peroxisome Proliferator-Activated Receptors (PPAR)γ Agonists as Master Modulators of Tumor Tissue
Published in International journal of molecular sciences (09-11-2018)“…In most clinical trials, thiazolidinediones do not show any relevant anti-cancer activity when used as mono-therapy. Clinical inefficacy contrasts ambiguous…”
Get full text
Journal Article -
2
The complex intervention day hospice - a quality-assured study on the implementation, realization, and benefits with model character for Germany (IMPULS) using the example of "Day hospice Adiuvantes"
Published in BMC palliative care (16-01-2024)“…Currently, a conclusive experience on the uniform implementation and benefits of day hospice structures and interventions is lacking in Germany. The following…”
Get full text
Journal Article -
3
Low-density lipoprotein balances T cell metabolism and enhances response to anti-PD-1 blockade in a HCT116 spheroid model
Published in Frontiers in oncology (27-01-2023)“…The discovery of immune checkpoints and the development of their specific inhibitors was acclaimed as a major breakthrough in cancer therapy. However, only a…”
Get full text
Journal Article -
4
Clinical Efficacy of a Novel Therapeutic Principle, Anakoinosis
Published in Frontiers in pharmacology (28-11-2018)“…Classic tumor therapy, consisting of cytotoxic agents and/or targeted therapy, has not overcome therapeutic limitations like poor risk genetic parameters,…”
Get full text
Journal Article -
5
Immunometabolic Markers in a Small Patient Cohort Undergoing Immunotherapy
Published in Biomolecules (Basel, Switzerland) (18-05-2022)“…Although the discovery of immune checkpoints was hailed as a major breakthrough in cancer therapy, generating a sufficient response to immunotherapy is still…”
Get full text
Journal Article -
6
Determinants of completion of advance directives: a cross-sectional comparison of 649 outpatients from private practices versus 2158 outpatients from a university clinic
Published in BMJ open (01-12-2017)“…ObjectivesTo compare outpatients from private practices and outpatients from a university clinic regarding the determinants of completion of advance directives…”
Get full text
Journal Article -
7
Biomodulatory therapy approach with lenalidomide in combination with pioglitazone, dexamethasone, and metronomic low-dose chemotherapy with treosulfan in patients with relapsed/refractory multiple myeloma > second-line
Published in Journal of clinical oncology (20-05-2019)“…Abstract only 8037 Background: Nowadays, therapy for relapsed or refractory multiple myeloma (rrMM) usually consists of multi-targeted combination regimens for…”
Get full text
Journal Article -
8
Palliative treatment of presacral recurrence of endometrial cancer using irreversible electroporation: a case report
Published in Journal of medical case reports (13-05-2013)“…Irreversible electroporation (IRE) is a new minimally invasive tumor ablation technique which induces irreversible disruption of cell membrane integrity by…”
Get full text
Journal Article -
9
Anakoinosis: kommunikative Netzwerke im Tumorsystem reprogrammieren
Published in Im Fokus Onkologie (01-12-2017)Get full text
Journal Article -
10
Therapie von Thymomen und Thymuskarzinomen
Published in Best practice onkologie (01-09-2017)“…Zusammenfassung Hintergrund Thymome und Thymuskarzinome (TK) zählen zu den häufigsten primären malignen Raumforderungen im vorderen Mediastinum. Ziel der…”
Get full text
Journal Article